Skip to content

RNTX - Rein Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchR

Rein Therapeutics Inc

RNTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

R

RNTXRein Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.18
52-wk low: $0.69
Prev close: $1.45
Mkt cap: $68.3M
Beta: 1.37
P/B: 6.6x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$4.7M

CI
Citadel
Ken Griffin · Q2 2026 13F
$2.5M
position
SE
Senvest
Richard Mashaal · Q2 2026 13F

Earnings

Reported May 15, 2026

Earnings came in 61.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $68M

Valuation

P/B6.57

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: RNTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $68.32M
Beta: 1.37

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-163.4%

$1.3M

position

TS

Two Sigma

Q4 2025 13F

$48K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for RNTX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19+61.2%

-$0.49 expected

Next report

What the street expects next

EPS expected

-$0.09

-$0.10 to -$0.08

Revenue expected

$0.00

2 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

-163.4%

ROA-32.1%

Growth

Beta1.37